Stay updated on Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.

Latest updates to the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the page and removed older entries including the funding status notice and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding and current NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded Show glossary and updated QC metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and removed older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe changes are minor revision notes: added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter updates: Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 on the Study Details page.SummaryDifference0.0%

Stay in the know with updates to Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.